StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Abbvie (ABBV) PT Raised to $154 at BMO Capital
February 3, 2022 7:19 AM
BMO Capital analyst Gary Nachman raised the price target on Abbvie (NYSE: ABBV) to $154.00 (from $153.00) while maintaining an ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Abbvie (ABBV) PT Raised to $122 at Goldman Sachs
February 3, 2022 6:43 AM
Abbvie (ABBV) PT Raised to $138 at BofA Securities
February 3, 2022 5:45 AM
Abbvie (ABBV) PT Raised to $150 at Barclays
February 3, 2022 4:55 AM
Form 8-K AbbVie Inc. For: Feb 02
February 2, 2022 7:48 AM
AbbVie sees strong 2022 earnings as Botox, Skyrizi power profit beat
February 2, 2022 7:45 AM
AbbVie (ABBV) Tops Q4 EPS by 3c, Offers Guidance
February 2, 2022 7:44 AM
AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial Results
February 2, 2022 7:43 AM
